162 related articles for article (PubMed ID: 19544367)
1. Relative uptake of minoxidil into appendages and stratum corneum and permeation through human skin in vitro.
Grice JE; Ciotti S; Weiner N; Lockwood P; Cross SE; Roberts MS
J Pharm Sci; 2010 Feb; 99(2):712-8. PubMed ID: 19544367
[TBL] [Abstract][Full Text] [Related]
2. Effect of tocopheryl polyethylene glycol succinate on the percutaneous penetration of minoxidil from water/ethanol/polyethylene glycol 400 solutions.
Sheu MT; Wu AB; Lin KP; Shen CH; Ho HO
Drug Dev Ind Pharm; 2006 Jun; 32(5):595-607. PubMed ID: 16720414
[TBL] [Abstract][Full Text] [Related]
3. Relative influence of ethanol and propylene glycol cosolvents on deposition of minoxidil into the skin.
Tata S; Weiner N; Flynn G
J Pharm Sci; 1994 Oct; 83(10):1508-10. PubMed ID: 7884676
[TBL] [Abstract][Full Text] [Related]
4. New ethanol and propylene glycol free gel formulations containing a minoxidil-methyl-β-cyclodextrin complex as promising tools for alopecia treatment.
Lopedota A; Cutrignelli A; Denora N; Laquintana V; Lopalco A; Selva S; Ragni L; Tongiani S; Franco M
Drug Dev Ind Pharm; 2015 May; 41(5):728-36. PubMed ID: 24650036
[TBL] [Abstract][Full Text] [Related]
5. Minoxidil-encapsulated poly(L-lactide-co-glycolide) nanoparticles with hair follicle delivery properties prepared using W/O/W solvent evaporation and sonication.
Takeuchi I; Hida Y; Makino K
Biomed Mater Eng; 2018; 29(2):217-228. PubMed ID: 29457595
[TBL] [Abstract][Full Text] [Related]
6. Follicular and percutaneous penetration pathways of topically applied minoxidil foam.
Blume-Peytavi U; Massoudy L; Patzelt A; Lademann J; Dietz E; Rasulev U; Garcia Bartels N
Eur J Pharm Biopharm; 2010 Nov; 76(3):450-3. PubMed ID: 20600888
[TBL] [Abstract][Full Text] [Related]
7. Iontophoresis-targeted, follicular delivery of minoxidil sulfate for the treatment of alopecia.
Gelfuso GM; Gratieri T; Delgado-Charro MB; Guy RH; Vianna Lopez RF
J Pharm Sci; 2013 May; 102(5):1488-94. PubMed ID: 23450524
[TBL] [Abstract][Full Text] [Related]
8. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery.
Balakrishnan P; Shanmugam S; Lee WS; Lee WM; Kim JO; Oh DH; Kim DD; Kim JS; Yoo BK; Choi HG; Woo JS; Yong CS
Int J Pharm; 2009 Jul; 377(1-2):1-8. PubMed ID: 19394413
[TBL] [Abstract][Full Text] [Related]
9. Penetration of minoxidil from ethanol/propylene glycol solutions: effect of application volume and occlusion.
Tata S; Flynn GL; Weiner ND
J Pharm Sci; 1995 Jun; 84(6):688-91. PubMed ID: 7562405
[TBL] [Abstract][Full Text] [Related]
10. Drug and vehicle deposition from topical applications: use of in vitro mass balance technique with minoxidil solutions.
Tsai JC; Cappel MJ; Flynn GL; Weiner ND; Kreuter J; Ferry JJ
J Pharm Sci; 1992 Aug; 81(8):736-43. PubMed ID: 1403715
[TBL] [Abstract][Full Text] [Related]
11. Development of ciclopirox olamine topical formulations: evaluation of drug release, penetration and cutaneous retention.
Pinheiro VA; Serikaku D; Baby AR; Velasco MV; Kaneko TM; Consiglieri VO
Pharm Dev Technol; 2015 Mar; 20(2):197-203. PubMed ID: 24286179
[TBL] [Abstract][Full Text] [Related]
12. Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil: in vitro evaluation of drug permeation by infrared spectroscopy.
Mura S; Manconi M; Fadda AM; Sala MC; Perricci J; Pini E; Sinico C
Pharm Dev Technol; 2013; 18(6):1339-45. PubMed ID: 22563642
[TBL] [Abstract][Full Text] [Related]
13. Topical formulations containing finasteride. Part II: determination of finasteride penetration into hair follicles using the differential stripping technique.
Tampucci S; Burgalassi S; Chetoni P; Lenzi C; Pirone A; Mailland F; Caserini M; Monti D
J Pharm Sci; 2014 Aug; 103(8):2323-9. PubMed ID: 24916447
[TBL] [Abstract][Full Text] [Related]
14. Squarticles as a lipid nanocarrier for delivering diphencyprone and minoxidil to hair follicles and human dermal papilla cells.
Aljuffali IA; Sung CT; Shen FM; Huang CT; Fang JY
AAPS J; 2014 Jan; 16(1):140-50. PubMed ID: 24307611
[TBL] [Abstract][Full Text] [Related]
15. Preparation and in vivo evaluation of lecithin-based microparticles for topical delivery of minoxidil.
Lee HJ; Oh DW; Na MJ; Kim DW; Yuk DY; Choi HC; Lee YB; Han K; Park CW
Arch Pharm Res; 2017 Aug; 40(8):943-951. PubMed ID: 28770536
[TBL] [Abstract][Full Text] [Related]
16. Influence of application time and formulation reapplication on the delivery of minoxidil through hairless mouse skin as measured in Franz diffusion cells.
Tsai JC; Flynn GL; Weiner N; Ferry JJ
Skin Pharmacol; 1994; 7(5):270-7. PubMed ID: 8054209
[TBL] [Abstract][Full Text] [Related]
17. Propylene glycol free 5% minoxidil lotion formulation: cosmetic acceptability, local tolerability, clinical efficacy and in-vitro skin absorption evaluations.
Barbareschi M; Vescovi V; Starace M; Piraccini BM; Milani M
G Ital Dermatol Venereol; 2020 Jun; 155(3):341-345. PubMed ID: 32635707
[TBL] [Abstract][Full Text] [Related]
18. Drug and vehicle deposition from topical applications: localization of minoxidil within skin strata of the hairless mouse.
Tsai JC; Weiner N; Flynn GL; Ferry JJ
Skin Pharmacol; 1994; 7(5):262-9. PubMed ID: 8054208
[TBL] [Abstract][Full Text] [Related]
19. Iontophoresis of minoxidil sulphate loaded microparticles, a strategy for follicular drug targeting?
Gelfuso GM; Barros MA; Delgado-Charro MB; Guy RH; Lopez RF
Colloids Surf B Biointerfaces; 2015 Oct; 134():408-12. PubMed ID: 26222406
[TBL] [Abstract][Full Text] [Related]
20. Minoxidil Skin Delivery from Nanoemulsion Formulations Containing Eucalyptol or Oleic Acid: Enhanced Diffusivity and Follicular Targeting.
Abd E; Benson HAE; Roberts MS; Grice JE
Pharmaceutics; 2018 Jan; 10(1):. PubMed ID: 29370122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
